ABSTRACT α-Synuclein (α-SN) is a ubiquitous protein that is especially abundant in the brain and has been postulated to play a central role in the pathogenesis of Parkinson's disease, Alzheimer's disease, and other neurodegenerative disorders. However, little is known about the neuronal functions of α-SN and the molecular and cellular mechanisms underlying neuronal loss. Here, we show that α-SN plays dual roles of neuroprotection and neurotoxicity depending on its concentration or level of expression. At nanomolar concentrations, α-SN protected neurons against serum deprivation, oxidative stress, and excitotoxicity through the PI3/Akt signaling pathway, and its protective effect was increased by Bcl-2 overexpression. Conversely, at both low micromolar and overexpressed levels in the cell, α-SN resulted in cytotoxicity. This might be related to decreased Bcl-xL expression and increased bax expression, which is subsequently followed by cytochrome c release and caspase activation and also by microglia-mediated inflammatory responses via the NFκB and mitogen-activated protein kinase pathways.
pM in cerebrospinal fluid (CSF) (9) . α-SN is reported to be secreted into the CSF and found in the plaques in human AD brain as well as Tg2576 transgenic AD model mice brain, diffuse Lewy body disease (DLB), and PD, suggesting that full-length α-SN is released by neurons, either as part of normal cellular processing or, alternatively, as a result of neuronal degeneration and death (9) (10) (11) (12) . Supporting this recent finding that extracellularly applied α-SN induces cell death in human neuroblastoma SH-SY5Y cells is the implication that α-SN secreted into or present in the extracellular space may exert its cytotoxic effect on neighboring neuronal cells, and the concentration of α-SN may therefore be increased in the brains of patients with neurodegenerative diseases (9, 13, 14) . If α-SN concentration is high inside neurons, which accelerates neuronal death, it could be possible that leakage of α-SN occurs from the dead neurons and spreads cytotoxicity to neighboring cells. Sung et al. also reported that extracellularly applied α-SN entered the cell by endocytosis through the binding of Rab 5A and exerted a similar effect as nonaggregated intracellular α-SN, indicating that released α-SN can be uptaken by neighboring neurons and have an effect (15) .
In addition to being implicated in many aspects of neurodegenerative disease, α-SN expression was found to be modulated in cases of neuronal remodeling, namely songbird learning (16) . Its redistribution to the membrane fraction might also be important for events later in neuronal development and in synaptogenesis (17) . However, our current knowledge of the biology of α-SN is insufficient to understand how it might affect cell viability, specifically with respect to its seemingly opposite effects of neuroprotection and neurotoxicity (18) (19) (20) .
In this study, we provide the first direct evidence that α-SN has neuron-specific effects, which are dependent on its concentration or expression level. At nanomolar concentrations, α-SN protected neurons against cellular stress conditions such as serum deprivation, oxidative stress, and excitotoxicity through the PI3/Akt signaling pathway, and its protective effect was increased by Bcl-2 overexpression. In contrast, α-SN at either low micromolar concentrations or overexpressed levels induced cytotoxicity. This cytotoxicity, which is also influenced by the overexpression of Bcl-2, might be mediated by decreased Bcl-xL expression and increased bax expression subsequently followed by cytochrome c release and caspase activation and by the microglia-mediated inflammatory response via the transcription factor NFκB and mitogen-activated protein kinase (MAPK) pathways. Furthermore, we could detect released α-SN in the media of α-SN-transfected cells.
Taken together, these results strongly suggest that α-SN is released from the neuron and/or much more easily released or liberated from dying neurons, leading to uptake by surrounding neurons. In the nanomolar concentration range, α-SN could protect neurons against cellular stresses such as hypoxia, excitotoxicity, and oxidative stress, but at micromolar concentrations or at high expression level, although we cannot exactly control its expression level, it may induce neuronal death.
MATERIALS AND METHODS

Antibodies
Two different antibodies were used for immunodetection of α-SN: ASY-1, a rabbit polyclonal antibody generated against α-SN (a gift from Dr. P. H Jensen, University of Aarhus, Denmark), and FR1, a rabbit polyclonal antibody against maltose binding protein α-SN [1-140] (a gift from Dr. C. Haass, Ludwig Maximilians University, Germany). A mouse polyclonal antibody against Bcl-2, a mouse monoclonal antibody against Bcl-xL, and a rabbit polyclonal antibody against bax (Santa Cruz Biotechnology, Santa Cruz, CA) were used for immunodetection of Bcl-2, Bcl-xL, and bax, respectively. Anti-goat polyclonal c-Jun NH 2 -terminal kinase (JNK) antibody, anti-mouse polyclonal phospho-JNK antibody, anti-rabbit polyclonal cytochrome c antibody (Santa Cruz Biotechnology), anti-active caspase 3 antibody (Transduction Laboratories, Lexington, KY), anti-phospho-extracellular signal-regulated protein kinase (ERK) antibody (New England Biolabs, MA), anti-IκB (Sigma, St. Louis, MO), and anti-rabbit inducible nitric oxide synthase (iNOS) antibody (Sigma) were used for detection of JNK, phospho-JNK, cytochrome c, active caspase 3, phospho-ERK, IκB, and iNOS, respectively. Horseradish peroxidase-conjugated goat anti-mouse and goat anti-rabbit secondary antibodies were obtained from Amersham Pharmacia Biotech (Piscataway, NJ).
Preparation of recombinant α-SN
We expressed human α-SN construct by ligating the NcoI and Bglll fragment excised from pBSk α-SN (a generous gift from T. Saitoh, University of California, San Diego) into pET-3d digested with NcoI and BamHI and transformed into Escherichis coli, BL21(De3)pLyss. Protein (Mw. 14,432) was purified by using heat treatment and two-step column chromatography; Q-sepharose ion-exchange column followed by Sephacryl H100 size exclusion chromatography and lyophilized. The concentration of α-SN was determined by the BCA protein assay method.
Plasmid α-SN cloning
Wild-type α-SN 140 was prepared from human α-SN construct. A polymerase chain reaction (PCR) product was obtained by means of the following primers, 5'-GGG GTA CCC ATG GAT GTA TTC ATG AAA-3' containing the KpnI restriction site and 5'-GCT CTA GAG CTT AGG CTT CAG GTT CGT-3' containing the XbaI site. The PCR fragment was cut with KpnI and XbaI and then subcloned in His A pcDNA3 (Invitrogen, San Diego, CA), and the identity of α-SN was confirmed by entire sequencing analysis.
Cell culture and observation
For primary neuron culture, cerebral cortex was dissected out from embryonic day 16-17 Sprague-Dawley (SD) rat embryos and dissociated by gentle trituration. Cells were plated in 96-well plates coated with polyethyleneimine (0.2 mg/ml in sodium borate buffer, pH 8.3). After overnight incubation in Dulbecco's modified Eagle's medium (DMEM, Gibco BRL, NY) supplemented with 10% heat-inactivated fetal bovine serum (FBS, Gibco BRL), the media was replaced by serum-free defined medium for neurons (DMEM supplemented with 2 mM glutamine, 1 mM pyruvate, penicilin-streptomycin-amphotericin B mixture [Gibco BRL], 5 mM HEPES, 0.5% glucose, 10 µg/ml insulin, 30 nM sodium selenite, 20 nM progesterone, 100 µM putrescine, and 20 ng/ml transferrin). The cultured cells were incubated at 37 o C in 5% CO 2 , and the media was replaced every other day. Cytosine arabinoside (20 µM; Sigma) was added on the culture for neuronal pure culture. After 14-15 days, cultured cells were treated with the peptides or drugs for indicated times.
For primary glial preparation, cerebral cortex was dissected out from 1-day-old neonatal SD rats and dissociated by gentle trituration. To distinguish microglia from other cells, confluently grown cultures were shaken for 8 h at room temperature. Then dislodged layers were transferred to culture dish (TPP, Trasadingen, Switzerland) for 30 min, and media with unattached cells was discarded to prepare microglia cultures. Glial cells had been incubated and were cultivated in an incubator in DMEM supplemented with 10% heat-inactivated FBS at 37 o C in 5% CO 2 . For pure microglial culture, we confirmed the stimulation and expression of glial fibrillary acidic protein by lipopolysacchride, using immunohistochemical staining and Western blot for each batch.
PC12 cells (ATCC CRL1721) were grown in DMEM supplemented with 10% FBS and penicillin/streptomycin and were under 5% CO 2 at 37 o C. Also, Bcl-2-overexpressed PC12 cells (gift from Dr Lee and Dr. Miller, University of Chicago) (21) were grown in 10% FBS in DMEM plus penicillin/streptomycin and geneticin (G418, Gibco BRL) under 5% CO 2 at 37 o C. To induce neuronal differentiation, cells were plated on polyethylenimine-coated 100-mm culture dish, and the day following plating, treatments with nerve growth factor (NGF, 100 ng/mL) were performed for 3 days. For serum deprivation, cells were rinsed with NGF-and serum-free medium and subjected to NGF-and serum-free medium for 24-48 h because neuronal differentiated PC12 cells can be induced to undergo apoptosis by withdrawal of NGF under serum-free conditions.
Stable transfection
For experiments involving Bcl-2, PC12 cells were transduced with a pCMV7 retrovirus vector containing cDNA encoding Bcl-2 or with pCMV7 without an insert and then selected with geneticin, as described previously (21) . In brief, selection was begun after 48 hr by 1:10 dilution of the cells in medium containing 1000 µg of geneticin per ml. Two days following initiation, selective antibiotic concentration was reduced to 500 µg of geneticin per ml. After 1 wk of selection, surviving cells were pooled and used to produce retrovirus. Expression of the transduced Bcl-2 was confirmed by immunohistochemical staining and Western blot (21) .
Transient transfection
For transfection, PC12 and PC12/Bcl-2 cells (2 × 10 5 cells/35-mm dish) were transiently transfected with 4 µg of plasmid DNA. Plasmid DNAs of wild-type α-SN or HisA pcDNA3 dissolved in DMEM were mixed with the DMEM containing 2 µl of FuGene 6 (Boehringer Mannheim, Mannheim, Germany). The mixture was incubated at room temperature for 45 min and treated into the cells. After 6 h, the media were replaced by 10% FBS containing DMEM. The samples for experiments were prepared 48 h posttransfection.
Viability assay
Viability was measured by LDH assay and MTT reduction assay as described previously (22) . In brief, cells plated on 96-well plates were grown in completed medium until they reached 30-50%. After treatment with α-SN or pharmacological agents for the indicated time, LDH activities in the medium were measured by a Cytotox 96 nonradioactive cytotoxicity assay kit (Promega, Madison, WI) according to the manufacturer's instructions. The results were expressed as percentages of maximum LDH release obtained on complete cell lysis following 10% Triton X-100 treatment. The culture of vehicle treatment of DMEM with serum was defined as the negative control (0%).
MTT reduction assay was performed as described previously (22) . In brief, after treatment, MTT (Sigma) diluted in PBS was added to the culture medium to a final concentration of 1.5 mg/ml, and all samples were incubated at 37 o C for 3-4 h. Next, medium was removed, and precipitated MTT salts were solubilized in DMSO. The absorbencies at 570 nm were measured with an ELISA reader (Molecular Devices, CA). Assay values obtained from cultures of vehicle treatment or DMEM with serum were taken as 100%, and complete inhibition of MTT reduction (0%) was defined as the value obtained following the incubation with 10% Triton X-100.
Detection of cytochrome c release
Cells were lysed in a lysis buffer containing 180 mM KCl, 5 mM MgCl 2 , 25 mM Tris-HCl (pH 7.4), and protease inhibitors. After sonication, the mitochondrial and cytosolic fractions were obtained according to a previously described method (23) . Cytosol (50 µg) and mitochondria (50 µg) fractions were resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (15%) and blotted onto a nitrocellulose membrane (pore size, 0.2 µm), and cytochrome c or caspase-3 was identified with primary and secondary antibodies as previously described. The immunoblotting signal was visualized with an ECL kit (Amersham).
Western blot analysis
Cultured cells were washed twice with ice-cold phosphate-buffered saline (PBS), trypsinized with 0.25% trypsin, centrifuged at 1000 rpm for 10 min, and suspended with lysis buffer (pH 7.5, 50 mM Tris-Cl, 150 mM NaCl, 5 mM EDTA, 1% TtitonX-100), including a protease inhibitor cocktail (Boeheringer Mannheim) and sonicated for 10 s. The lysates were centrifuged at 8000 rpm for 10 min. The protein levels were quantified using BioRad (Hercules, CA) Protein Assay Reagent. Samples were boiled for 5 min with the sample buffer (Tris-HCl, 62.5 mM, pH 6.8; SDS, 1%; β-mercaptoethanol, 1%; glycerol, 10%; bromophenol blue, 0.005% w/v), and the same amount of protein was subjected to each lane of SDS-PAGE. It was transferred onto nitrocellulose transfer membrane (Schleicher & Schuell, Dassel, Germany). The membrane was blocked for 1 h in 6% nonfat dry milk and probed with the primary antibody. After incubation for 1 h, with gentle agitation at room temperature, the blots were reacted with the horseradish peroxidase-coupled secondary immunoglobulin antibody at 1:1000 dilution for 1 h at room temperature. Between steps, blots were extensively washed with TBS-T three times for 30 min each time. The immunoreactive bands were visualized with the enhanced chemiluminescence detection system (Amersham).
Detection of α-SN release into media
α-SN released into cell culture media was concentrated by the protein concentration kit mainly according to the manufacturer's instructions (Rapid-ConTM protein concentration kit, ELPIS, Seoul, Korea). Then, the concentration of samples was measured and detected by Western blot analysis as described previously.
Assay for nitric oxide (NO) derivatives
NO 2 accumulation in the medium was used as an indicator of NO production as described previously (24) . The isolated supernatant was mixed with a volume of Griess reagent (1% sulfanilamide, 0.1% naphtylethylene diamine dihydrochloride, 2% phosphoric acid), and incubated for 12 min. NO was checked after 24 h of incubation with α-SN. The spectrophotometric absorbance was measured at 542 nm. The concentrations were determined using the standard curve obtained with sodium nitrite solution.
Evaluation of cytotoxicity of the microglial conditioned media
To evaluate the effects of microglial conditioned media on the neuronal viability, α-SN was added into the cultured microglia pretreated with 1 µM N,ω-nitro-L-arginine methyl ester (NAME; Sigma), 20 µM pyrrollidine dithiocarbamate (PDTC; Sigma), 50 µM SB203580 (Sigma), or 25 µM PD098509 (Sigma) 2 h before α-SN treatment. After the microglia were incubated with 2.5 µM of α-SN for another 12 h, the conditioned media of microglia were transferred into the cortical neuronal cultures. Neurons were incubated with these conditioned media from the microglia for 24 h.
Statistical analysis
Data are expressed as mean ±SE. Student's t tests were applied to study the relationship between the different variables. P<0.05 was considered to be significant.
RESULTS
The dual effects of α-SN on the rat primary cortical and hippocampal neuronal cells
To study the effect of α-SN on cell viability, rat cortical and hippocampal neuronal cells were treated with 0.1, 1, 10, or 20 µM α-SN for 3 days, and changes in MTT reduction and LDH activity were recorded. High concentrations of α-SN (10 and 20 µM) significantly reduced the MTT reduction level and resulted in a significant increase in LDH activity in a time-dependent manner, whereas nanomolar levels of α-SN did not (Fig. 1A) . Treatment with 0.1 µM α-SN had a significant effect in protecting the rat cortical and hippocampal neurons from neuronal death induced by serum deprivation; in contrast, treatment with 20 µM α-SN led to increased cell death (Fig. 1B) . As a control, addition of bacterial glutathione S-transferase prepared in the same recombinant expression system had no effect on cell viability in the rat primary cortical and hippocampal neuronal cells (data not shown), suggesting that the induction of cell death is a specific effect of α-SN.
The neurotoxic effects of α-SN on the various neuronal cells
In NGF-differentiated PC12 cells ( Fig. 2A) , and also in SHSY-5Y and GT1-1 cells (data not shown), α-SN showed a similar cytotoxic effect with that observed in rat primary neuronal cells; however, α-SN-induced cytotoxicity was decreased in PC12 cells overexpressing Bcl-2 (PC12-Bcl-2 cells). In addition, overexpressed α-SN also significantly induced neuronal cell death in PC12 cells as much as extracellular treatment with 10 µM of purified α-SN (Fig. 2B) . The level of cytotoxicity induced by α-SN was decreased in PC12-Bcl-2 cells in comparison with PC12 cells, however only the vector-transfected and control groups showed no cytotoxicity in both cells. Also, as a control, addition of bacterial glutathione S-transferase prepared in the same recombinant expression system had no effects on the cell viability in NGF-differentiated PC12 cells and SHSY-5Y and GT1-1 cells (data not shown), suggesting that the induction of cell death is a specific effect of α-SN.
The protective effects of α-SN on the various neuronal cells
Consistent with the results in rat primary neuronal cells, 0.1 µM α-SN was found to protect SHSY-5Y, GT1-1, and NGF-differentiated PC12 cells against serum deprivation (Fig. 3A, top  graph) . In addition, α-SN showed a protective effect against treatment with 200 µM hydrogen peroxide or 20 µM glutamate treatment in SHSY-5Y, GT1-1, and NGF-differentiated PC12 cells (Fig. 3A, middle and bottom graphs) . Serum deprivation-induced cytotoxicity was inhibited in both PC12-Bcl-2 and PC12 cells. The degree of inhibition was greater in PC12-Bcl-2 than in PC12 cells. Similarly, the protective effect of 0.1 µM α-SN treatment against serum deprivation or treatment with 200 µM hydrogen peroxide was greater in PC12-Bcl-2 cells than in PC12 cells (Fig.  3B) . In contrast, α-SN did not affect cell viability in U251 cells (human glial cell line), indicating that the toxic effects of α-SN may exhibit some form of a neuroselectivity (data not shown).
Possible protective mechanisms of α-SN
In PC12-Bcl-2 cells, 0.1 µM of α-SN increased Bcl-xL expression levels more significantly than in the control group but decreased bax expression (Fig. 4A) . Their mRNA levels showed similar patterns to the immunoblot analysis (Fig. 4B) . To identify the mechanism responsible for the anti-apoptotic effect of α-SN, we investigated the effect of α-SN on the protooncogenic serine/threonine kinase (Akt), a molecule involved in the transduction of antiapoptotic signals (25, 26) . Activation of Akt can be easily detected by Western blotting with antibodies that specifically recognize Akt molecules phosphorylated at serine 473, because this phosphorylation correlates with Akt activity (25) . Expression of phosphorylated Akt (pAkt) was increased in PC12 and PC12-Bcl-2 cells treated with 0.1 µM α-SN (Fig. 4C) . Because Akt activation, in most instances, is dependent on phosphatidylinositol 3-kinase (PI3K) (25), we tested the nonrelated PI3K inhibitor LY294002, and the expression of pAkt by α-SN was prevented by the pretreatment of 20 µM LY294002 (Fig. 4C) . And the pretreatment of PI3 inhibitor also decreased this antiapoptotic effect about the neuronal death (Fig. 4D) .
Possible neurotoxic mechanisms of α-SN
After the treatment with 10 µM α-SN or its transient transfection for 2 days, levels of Bcl-xL were decreased, but the level of bax was increased in PC12 and PC12-Bcl-2 cells (Fig. 5A and 5B). In addition, transfected α-SN and extracellularly applied α-SN increased both the expression and phosphorylation of JNK ( Fig. 5A and 5B). To clarify the downstream signaling cascades of α-SN, we investigated cytochrome c and caspase-3, which are downstream from the Bcl-2 family proteins in apoptotic signaling. Treatment with 10 µM α-SN induced a increase of cytochrome c in the cytosolic fraction. In contrast, it induced a decrease of cytochrome c in the mitochondria fraction in a time-dependent manner from the initial day of treatment for 3 days in SHSY-5Y, a human neuroblastoma cell line (Fig. 5C ).
Consistently, caspase-3 activation and bax expression were observed. Cells transfected with α-SN expressed two-to threefold higher levels of mRNA for α-SN than mock-transfected and nontransfected control cells (data not shown). α-SN was detected as a 19-kDa band in whole-cell lysate and in the media after transfection of α-SN (Fig. 5B, right 5th and 6th panel) .
Inflammatory responses induced by α-SN in rat cortical microglia
To determine the effects of α-SN on microglial activation at low micromolar concentrations of α-SN, levels of NO and iNOS were examined in rat cortical microglia incubated with 1 µM α-SN. We also examined the effects of NAME, PDTC, PD098059, or SB203580 on iNOS expression and NO production. Levels of NO increased time-and dose-dependently (data not shown), and this induction of NO was blocked by pretreatment with NAME, PDTC, PD098059, or SB203580 (Fig.  6A ). In addition, iNOS expression was also blocked by the pretreatment of PDTC, PD098059, or SB203580 (Fig. 6B) . Microglial iNOS levels were examined with time-course preparations, using Western blot analysis. iNOS showed a time-dependent increase (Fig. 6C) .
To ascertain whether NFκB is associated with α-SN-induced NO production, we incubated microglia with 1 µM α-SN for times indicated and checked Iκ-B degradation in microglia incubated with α-SN by means of immunoblot analysis. Iκ-B was degraded from 6 h after α-SN treatment as shown in Figure 6C . In contrast, the JNK and phospho-ERK levels were increased from 12 h after α-SN treatment (Fig. 6C) . We also confirmed the increment of tumor necrosis factor (TNF)-α mRNA levels from microglia that were incubated with 1 µM α-SN (data not shown).
To examine the net toxic effects of microgliosis on the neuronal survival, neuronal cultures were incubated with the conditioned media from microglia incubated with 2.5 µM α-SN. Neuronal MTT reduction was significantly reduced as shown in Figure 6D . This neuronal death was blocked by a 2-h pretreatment of 1 µM NAME, 20 µM PDTC, 50 µM SB203580, or 25 µM PD098509 (Fig.  6D) .
DISCUSSION
α-SN is a naturally unfolded protein of 140 amino acids, which constitutes about 0.1% of the soluble fraction of whole brain lysate (27) . Recently, it has been shown that α-SN might play a role in the regulation of synaptic plasticity such as in songbird learning (16) , neuronal differentiation (28, 29) , up-regulation of dopamine release (30, 31) , and mitochondrial deficits (32) (33) (34) (35) , and it has a chaperone-like activity (36, 37) . However, the primary physiological function of α-SN still remains to be elucidated.
In the present study, we first provide direct evidence that α-SN at nanomolar concentrations could protect neurons against the cellular stress conditions such as serum deprivation, glutamate toxicit, and oxidative stress caused by hydrogen peroxide. Its protection effect against neurotoxicity is observed at physiological range and mediated by activation of the prosurvival PI3K/Akt pathway followed by Bcl-2 family anti-apoptotic expression. The survival effect by α-SN was more increased by the Bcl-2 stable transfection, and also the pretreatment of PI3 inhibitor decreased this antiapoptotic effect about the neuronal death. Thus, it is implicated that the activation of the PI3K/Akt and Bcl-2 family expression pathways might be responsible for its protective effect. Recently, PI3K and its downstream effector, the serine/threonine kinase (Akt), were reported to play roles in neuronal survival (38) (39) (40) . For example, the overexpression of activated PI3K and Akt promoted the survival of superior cervical neurons in culture (38) , and activated Akt stimulated changes in Bcl-2 and bax expression and showed the anti-apoptotic effect in several different cell types, including hippocampal neurons and PC12 cells (41, 42) . Supporting this, the activation of Akt has been shown to lead to phosphorylation of Bad, thereby decreasing the interaction of bad with Bcl-xL and increasing the Bcl-xL/bad ratio, and also to phosphorylation of caspase-9, leading to its inactivation and eventually promoting cell survival (43, 44) . One remaining question about this protective mechanism of PI3K/Akt is how α-SN can switch on this activation or be involved in this pathway. The details of this mechanism remain to be further studied.
In the present study, we also showed that overexpression or high concentrations of α-SN exerted a significant cytotoxic effect by decreasing Bcl-xL expression and increasing bax levels followed by cytochrome c release and caspase activation and by microglia-mediated inflammatory response. So far, according to many pathological reports, α-SN is the major component of intracellular inclusions in PD, DLB, and MSA. However, it is proposed that the formation of neuronal inclusions by α-SN aggregation and the development of neuronal deficits might not be causally linked (45) , and there is growing evidence that neuronal apoptosis in the absence of obvious pathological deposits could also have a highly significant effect on the pathogenesis of neurodegenerative diseases (2, 7, 46) . Therefore, LB or the aggregation of α-SN into insoluble filamentous structures might not represent a pathological condition but is probably just a hallmark of several neurodegenerative diseases, and several studies have recently reported that overexpressed α-SN causes cytotoxicity in several neuronal cell types such as dopaminergic neurons, sympathetic neurons, and SHSY-5Y cells (13, (47) (48) (49) . Furthermore, extracellular application of α-SN caused a significant decrease in the cell viability of primary and immortalized neuronal cells via Rab5A-dependent endocytosis (14, 15) . Taken together, these results make it plausible to imply that the high concentration of free α-SN in either the extracellular or the intracellular space might play a cytotoxic role in the pathology of several neurodegenerative diseases.
Recently, it has been demonstrated that α-SN in the defining lesions of synucleinopathies are specifically nitrated (50, 51) . The selective nitration of α-SN provided direct evidence for showing that nitrative and oxidative stresses play highly significant roles in the onset and progression of various synucleinopathies (50, 51) . However, there have been no reports on the origin of this nitration. In this study, our data strongly suggest that nitration is caused by NO from the microglia that are situated near the neurons. Once the extracellular concentration of α-SN increases to greater than a few micromolars under pathological conditions, it may activate neighboring microglia to produce NO via the MAPK pathway and NFκB translocation. The highly diffusible NO released from microglia would nitrate α-SN in neurons, increasing toxicity and ultimately inducing neuronal death. Most likely, therefore increased α-SN in dying neurons damaged by microglia activation could diffuse out after neuronal rupture and exert a direct neurotoxic effect, through an increase in the ratio of pro-to anti-apoptotic signaling molecules, which in turn build a positive feedback loop.
In this study, we have demonstrated that treatment with high concentrations or overexpression of α-SN leads to up-regulation of bax expression, an increase in caspase activity, and subsequent release of cytochrome c from mitochondria, even though we cannot control exactly the expression level of α-SN. In supporting of our results, translocation of cytosolic bax into mitochondria induces cytochrome c release to activate caspase-3, leading to cell death. In contrast, Bcl-2 and Bcl-xL expression can block apoptosis by inhibiting bax expression and conformational changes (43, 44, 52, 53) . Moreover, it has been recently reported that α-SN interacts with dephospho-bad (37) . Dephospho-bad is known to stimulate Bax to undergo allosteric activation, leading to facilitate mitochondrial membrane permeabilization, which is inhibited by the anti-apoptotic members of the Bcl-2 family (43, 44) . This interaction could provide another underlying molecular basis of the pro-apoptotic effect induced by α-SN in cultured neurons.
In summary, our results provide the first evidence that low or physiological levels of α-SN can protect neurons against various toxic insults such as hypoxia, oxidative stress, and glutamate toxicity via the PI3/Akt pathway. In contrast, high concentrations or overespression of α-SN exert a cytotoxic effect on neurons, which apparently might be linked to the Bcl-2 family-related caspase pathway and inflammatory events to produce NO, suggesting another new role of α-SN in the pathogenesis of neurodegenerative diseases such as AD and PD. A) Nitrite accumulation by 1 µM α-SN was measured with or without pretreatment of 1 µM NAME, 20 µM PDTC, 25 µM PD098059, or 50 µM SB203580 at 2 h before α-SN treatment. B) We investigated iNOS induced by incubation with 1 µM α-SN for 24 h with or without 2-h pretreatment of the indicated inhibitor. C) The expressions of Iκ-B, iNOS, JNK, and phosphorylated ERK by 1 µM of α-SN for the indicated time were examined by immunoblot analysis in primarily cultured microglia. D) Effects of conditioned media of α-SN-treated microglia on rat cortical neuronal viability were checked by MTT reduction assay with or without pretreatment of the indicated inhibitor at 2 h before α-SN treatment. *P < 0.05, significantly different from the control, by Student's t test, n = 8; C, control neuron group; 2.5 µM SN, 2.5 µM α-SN-treated neuron group; MCM CTL, 2.5 µM α-SN-treated microglia group; MCM 2.5 µM, neuron group incubated with the conditioned media obtained from 2.5 µM α-SN-treated microglia as described in Materials and Methods.
